Found 7 matching trials
Asciminib in HER2+ Breast Cancer Brain Metastases PHASE1 The purpose of this study is to evaluate the intracranial response rate of ...
Show More Learn More & Join Trial
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP PHASE2 The aim of this study is to support development of asciminib in the pediatr...
Show More Location
Rutgers Cancer Institute of New Jersey
Learn More & Join Trial
Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response. PHASE2 To evaluate efficacy, safety and pharmacokinetic profile of asciminib 40mg+...
Show More Location
Georgia Regents University
Learn More & Join Trial
Asciminib Roll-over Study PHASE4 This is a long term safety study for patients who have completed a Novartis...
Show More Location
Michigan Med University of Michigan
Learn More & Join Trial
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase PHASE2 This study is a multicenter Phase 2, non-randomized, open-label single-grou...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML PHASE2 A phase 2, interventional, randomized unblinded study will be conducted in ...
Show More Location
Hospital del Mar (Barcelona)
Learn More & Join Trial
Frontline Asciminib Combination in Chronic Phase CML PHASE2 Adult male and female patients with newly diagnosed Philadelphia chromosome...
Show More Status
Active Not Recruiting
Location
UniversitÀtsklinikum Aachen Medizinische Klinik IV
Learn More & Join Trial